Immunocompetent patients with pulmonary Mycobacterium kansasii infection: A case series and review of the literature

Clinical Pulmonary Medicine

Volumn 10, Issue 3, 2003, Pages 131-135

  Avnon, L Sølling ^a   Gelfer, E ^b   Heimer, D ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MINISTRY OF HEALTH   (Israel)

Author keywords

Diagnostic criteria; Immunocompetent host; Pulmonary Mycobacterium kansasii infection; Smoking as risk factor; Treatment

Indexed keywords

ADULT; CASE REPORT; CLINICAL FEATURE; HUMAN; IMMUNOCOMPETENCE; LUNG INFECTION; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRACTICE GUIDELINE; REVIEW; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

EID: 0038559589     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000068520.42813.46     Document Type: Review

References (26)

1. American Thoracic Society. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am Rev Resp Dis. 1990;142:940-953.
2. American Thoracic Society. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med. 1997;156:S1-S25.
3. Management of opportunistic mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Subcommittee of the Joint tuberculosis committee of the British Thoracic Society. Thorax. 2000;55:210-218.
4. Davies PDO. Infection with Mycobacterium kansasii. Thorax. 1994;49:435-436.
5. Bloch KC, Zwerling L, Pletcher MJ, et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: Results of a 5-year, population based study. Ann Intern Med. 1998;129:698-704.
6. Corbett EL, Churchyard GJ, Hay M, et al. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. Am J Respir Crit Care Med. 1999;160:10-14.
7. O'Brien RJ, Geiter LJ, Snider DE, Jr. The Epidemiology of nontuberculosis mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 1987;135:1007-1014.
8. Menziez D. Interpretation of Repeated Tuberculin Tests. Boosting, Conversion and reversion. Am J Respir Crit Care Med. 1999;159:15-21.
9. Lillo M, Orengo S, Cernoch P, et al. Pulmonary and disseminated infection due to Mycobacterium kansasii: A decade of experience. Rev Infect Dis. 1990;12:760-767.
10. Jacobson KL, Teira R, Libshitz HI, et al. Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis. 2000;30:965-969.
11. Christensen EE, Dietz GW, Ahn CH, et al. Radiographic manifestations of pulmonary Mycobacterium kansasii infections. AJR. 1997;131:985-993.
12. Zvetina JR, Maliwan N, Frederick WE, et al. Mycobacterium kansasii infection following primary pulmonary malignancy. Chest. 1992;102:1460-1453.
13. Evans SA, Colville A, Evans AJ, et al. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with the pulmonary tuberculosis. Thorax. 1996;51:1248-1252.
14. Contretas MA, Cheung OT, Sanders DE, et al. Pulmonary infection with nontuberculous mycobacterium. Am Rev Respir Dis. 1988;137:149-152.
15. Woods GL, Washington JA. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis. 1987;9:275-294.
16. Corbett EL, Blumberg L, Churchyard GJ, et al. Non tuberculous mycobacteria. Defining disease in a prospective cohort of South African miners. Am J Respir Crit Car Med. 1999;160:15-21.
17. Alcaide J, Altet MN, Plans P, et al. Cigarette smoking as a risk factor for tuberculosis in young adults: a case control study. Tuber Lung Dis. 1996;77:112-116.
18. Douglas AS, Strachan DP, Maxwell JP. Seasonality of tuberculosis: the reverse of other respiratory diseases in the UK. Thorax. 1996;51:944-946.
19. Rios M, Garcia JM, Sanchez JA, et al. A statistical analysis of the seasonality in pulmonary tuberculosis. Eur J Epidemiol. 2000;16:483-488.
20. Zvetina JR, Demos TC, Maliwan N, et al. Pulmonary cavitations in Mycobacterium kansasii. Distinctions from M. tuberculosis. AJR. 1984;143:127-130.
21. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine. 1990;69:307-316.
22. Evans AJ, Crisp AJ, Hubbard RB, et al. Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. Thorax. 1996;51:1243-1247.
23. Lewit T, Terracina S, Karman S, et al. Mycobacteriosis kansasii in Israel (Hebrew). Harefuah. 1975;88:367-369.
24. Richter E, Nieman S, Rusch-Gerds S, et al. Identification of Mycobateriun kansasii by using a DNA probe (accuprobe) and molecular techniques. J Clin Microbiology. 1999;37:964-970.
25. Research Committee, British Thoracic Society: Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampin and ethambutol. Thorax. 1994;49:442-445.
26. Francis BP, Jay SJ, Johanson WG. The course of untreated Mycobaterium kansasii disease. Am Rev Respir Dis. 1975;111:477-487.